Back to Ask the Diabetes Team Ask the Diabetes Team

From Oakland, California, USA:

My diabetes nurse once told me that people with type 1 diabetes usually produce minute amounts of insulin (measured by the C-peptide test) for 10 to 15 years after diagnosis. I have searched all over for a source to back this up, but haven't found anything except a doctor in Countdown who said that it is now suspected that up to 30% of people with type 1 diabetes produce insulin for life. Has anyone out there heard the 10 to 15 year idea? If so, is this backed up in the literature?


In type 1A (autoimmune) diabetes, some level of C-peptide can persist for as long as a year or even longer. In subjects who are already insulin dependent, the test is of little routine value clinically though, and is now primarily of use in those who were antibody negative at diagnosis. It is also used for those in whom no antibody test was done to see if they might actually have one of the variants of type 2 diabetes, one of the insulin resistance syndromes or perhaps type 1B diabetes. In these instances, normal or elevated levels of C-peptide could have a bearing on management.

I could find no specific reports of long term serial C-peptide measurements in autoimmune diabetes itself.


Original posting 17 Aug 2002
Posted to Other


  Back to Ask the Diabetes Team Return to the Top of This Page

Last Updated: Tuesday April 06, 2010 15:09:38
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.